ZYVERSA THERAPEUTICS, INC. — Income Charts
11 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+0.2% +$285
$-131K
R&D↓-16.3% -$71K
$365K
D&A↓-100.0% -$3K
$0
Operating Income↓-814.3% -$18M
$-21M
EBITDA↓-815.0% -$18M
$-21M
Interest Income
—
Other Income/Expense↑+172.1% +$227K
$95K
Pretax Income↓-760.3% -$18M
$-21M
Tax Provision
$-852K
Net Income↓-724.8% -$17M
$-20M
Operating Margin↑+14074.9pts
15799.1%
Net Margin↑+13254.3pts
15078.5%
Effective Tax Rate↑+4.1pts
4.1%
Deferred Tax Liabilities↓-100.0% -$10K
$0
Revenue YoY Variation↑+62583.5pts
0.2%
Income YoY Variation↓-836.2pts
-814.3%
Revenue QoQ Variation↑+226855.9pts
-1.0%
Income QoQ Variation↓-932.8pts
-915.2%